Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Cash return beckons for Arix shareholders investorschronicle.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorschronicle.co.uk Daily Mail and Mail on Sunday newspapers.
Biotherapeutics company PureTech Health, which develops medicines to treat serious diseases, has appointed the boss of Arix Bioscience as its new chief portfolio officer.
Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to unfavourable conditions while Chief Executive Officer Robert.